A recent CNN article contained good news for people who prefer not to have swabs inserted deep into their nostrils. The FDA has granted emergency use authorization for a COVID-19 breath test. The diagnostic tool identifies chemical compounds associated with the virus in breath, and can be used in medical offices and mobile testing sites. The test is called the InspectIR Covid-19 Breathalyzer, and it detects five compounds associated with SARS-CoV-2 infections. A study on the device found that it was able to accurately identify 91% of positive samples, and virtually 100% of negative samples. A video with more information can be seen here. Finally, a breathalyzer I wouldn’t mind taking!
FDA Clears First COVID-19 Breath Test
Move over painful swabs, now we have a breathalyzer that identifies compounds associated with SARS-CoV-2 infections.
Apr 22, 2022
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!